Teligent, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates primarily in the development and manufacturing of specialty generic pharmaceuticals. Founded in 2015, Teligent has quickly established itself as a leader in the production of injectable and topical formulations, focusing on quality and innovation. The company’s core offerings include a diverse range of sterile injectable products and topical medications, distinguished by their commitment to high standards and regulatory compliance. Teligent's strategic approach has enabled it to carve out a significant market position, with notable achievements in expanding its product portfolio and enhancing operational capabilities. With a focus on patient-centric solutions, Teligent continues to drive advancements in the pharmaceutical landscape.
How does Teligent, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Teligent, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Teligent, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As Teligent, Inc. does not inherit emissions data from a parent company, it operates independently in terms of climate commitments. Without specific emissions data or reduction initiatives, the company's climate strategy remains unclear. In the broader context of the industry, many companies are increasingly adopting science-based targets and committing to net-zero emissions, highlighting the importance of transparency and accountability in corporate climate action. However, Teligent, Inc. has yet to establish or communicate similar commitments.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Teligent, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
